Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I remember folks drumming up the contact Oprah nonsense on another failed pinky years back.
over $3 AH trading. That is close to 40% up for the week and FDA date in one week for approval. What an opportunity.
GNVC........strong after hours....they know. This is a company with a chance to be a major pharma down the line. This is not one of the bio site pump variety.
12/4 FDA approval decision date. Big run next week.
Slow bleed continues...holiday season may be slow for FDA..
I need to revise my estimate. Slow bleed to .48 rather than .70. Similar to the run on banks the more selling the more panickers who sell and the vicious cycle continues. Bottom line...nothing is cast in stone with FDA..timing or approval so why not take profits if not already a bagholder.
AHR...back in play......
As mentioned ...the bleed down to .70 is inevitable
No bash...IMGG is like many these days. It rose nicely from 3 cents as FDA resubmission approached without any help. Then the infantry, Biomed and others come aboard with to the moon and undervalued columns. And here you go ...folks pile in at all costs, frontloaders unload, and then the slow bleed until a credible event like the FDA decision. Everyday now it seems these folks are finding the next DNDN or VRMLQ...gotta laugh
A slow bleed down to .70 is inevitable as the FDA inevitably takes longer than anticipate to rule.
Isn't Medica where Viking has a booth and that is getting tons of play for VKNG>
Another Vermillion does not a BioMed column make. It takes just a wee bit more...don't ya think.
I do not believe those articles were for the benefit of new investors rather for the benefit of frontloaders dumping per the norm.
Gotta luv it when BioMed has the long weekend anticipated build to an article only to see no increase. guess that is what frontloading does.
More selling...is the deal toast?
Out of the dozens of bios I've held this one takes the cake for a lengthy FDA process that remains shrouded in secrecy. Nothing but play on words released by Carter. BS about supplemental v. requested studies. Which one is it? Who in the world really thinks FDA will approve ampligen. LOL. The Sage Group has done what for these group? This remains IMO but the most evasive, misleading, nonforthright bunch of bull I've ever invested in on the BIO side.
Is the management at CEL-SCI Corporation (AMEX:CVM) signaling that something big is coming?
Yes, IMO
OCNF..earnings were better than expected. This will move up here.
Well I won't argue...Goldman Saks may be a larger holder but certainly not Goldman Sachs. Typical HUB BS.
Why does this remind me of EPWN.... a penny classic from years past.
Keep eyes peeled........
IRSN.....this company is toast........was hyped on another pumper board where luck has mostly dried up. It's easy to pick stocks when everything is jumping 100% off bottoms. LOL......bio guru not much to say these days when every pick has hit the skids. Like I said easy to look like a champ when any PR was spiking a stock 100%. How the f do you annoint a guru who picks scam cos like RNN. Like I said....easy pickings in great times does make a guru not. Today pick some bio winners....not so simple ....huh.
When do folks learn....these frontloaders are not there for your benefit.
BTW...this board is really fair and reasonable....please stay that way....like the honesty on good and bad picks.
During the summer conference call............all that was needed was the very peculiar and evasive way Dr. Carter addressed FDA and communication therewith for me to loss complete credibility with him. I hope this gets approves someday but he comes across as a very cyptic character.
WTF happened to CVM. Biomedreports darling child w/ positive articles daily to nothing.
I don't think IHUB is a reliable source of anticipated share price....look at this POS right here..
Always amazed at the idiotics who panic and sell for a penny on the dollar. They are not dead yet....this drug can still have merit at the end of the road plus others in pipeline. LOL at the desperate panickers trying to salvage a nickle to gamble away on more pinks.
For something supposedly so long coming noone listened in. LOL. Yet folks invested souls here but didn't dial in to news several years coming. That is fishy to me..
so we should play along as if you have no access to news only the board...LOL
Still hope we are next....unfortunately Dr. Carter is probably right behind.
The manner in which they release the news w/o mention of any other pipeline promising drugs suggests to me they wanted the price to hit rock bottom so a deal can be finalized.
The worst part I would imagine for holders is the succinct brief and direct statement that the drug has failed to differentiate itself after all this nonsense.
I do not feel it's likely ampligen ever sees approval....ever
Would not viral causation throw ampligen out the window and a new approach needed.
The DD is that Carter has been trying for 15 years to get this approved. LOL. Are you kidding....
I am up to date just believe this one is least likely of all bios to get approval and least impressive company. Sage group has cut what deals for them. We have heard nada but continuing nonsense about some limited monkey work in Japan. Do you buy into Dr. Carter?
We need another call with the good doctor so he can slip up again on having communications with FDA and sending in supplements. Wonder what they've asked for now. 20 years and running on Ampligen. Is this a good drug or just a personal mission by the good doctor. Does anyone even care anymore.
Clear....not suggesting they received formal denial but maybe they need to start again. Does no one think strange that the infamous Amligen is still pending after six months. What a friggen farce and the best they can due is rehash japan news. $1.00 coming to this POS.
Is the company going to respond and refile.
Will they refile for approval for CFS for ampligen soon?